These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


518 related items for PubMed ID: 10459540

  • 1. A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment.
    Neipp M, Gammie JS, Exner BG, Li S, Chambers WH, Pham SM, Ildstad ST.
    Transplantation; 1999 Aug 15; 68(3):369-78. PubMed ID: 10459540
    [Abstract] [Full Text] [Related]

  • 2. A partial conditioning strategy for achieving mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment.
    Gammie JS, Li S, Colson YL, Demetris AJ, Neipp M, Ildstad ST, Pham SM.
    Exp Hematol; 1998 Sep 15; 26(10):927-35. PubMed ID: 9728927
    [Abstract] [Full Text] [Related]

  • 3. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG, Shuto Y, Soda Y, Nakazaki Y, Izawa K, Uchimaru K, Takahashi S, Tani K, Tojo A, Asano S.
    Exp Hematol; 2004 Dec 15; 32(12):1246-54. PubMed ID: 15588949
    [Abstract] [Full Text] [Related]

  • 4. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
    Colson YL, Li H, Boggs SS, Patrene KD, Johnson PC, Ildstad ST.
    J Immunol; 1996 Oct 01; 157(7):2820-9. PubMed ID: 8816385
    [Abstract] [Full Text] [Related]

  • 5. Combined host-conditioning with CTLA4-Ig, tacrolimus, anti-lymphocyte serum, and low-dose radiation leads to stable mixed hematopoietic chimerism.
    Li S, Thanikachalam M, Pang M, Carreno M, Aitouche A, Pham SM.
    Exp Hematol; 2001 Apr 01; 29(4):534-41. PubMed ID: 11301194
    [Abstract] [Full Text] [Related]

  • 6. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS, Li S, Zeevi A, Demetris AJ, Ildstad ST, Pham SM.
    Circulation; 1998 Nov 10; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [Abstract] [Full Text] [Related]

  • 7. A minimal conditioning approach to achieve stable multilineage mouse plus rat chimerism.
    Abou el-Ezz AY, Boggs SS, Johnson PC, Li H, Patrene KD, Itskowitz MS, Kaufman CL, Ildstad ST.
    Transpl Immunol; 1995 Jun 10; 3(2):98-106. PubMed ID: 7582911
    [Abstract] [Full Text] [Related]

  • 8. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD, Pham S, Li S, Aitouche A.
    Transplantation; 2003 Sep 27; 76(6):988-94. PubMed ID: 14508367
    [Abstract] [Full Text] [Related]

  • 9. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL, Wren SM, Schuchert MJ, Patrene KD, Johnson PC, Boggs SS, Ildstad ST.
    J Immunol; 1995 Nov 01; 155(9):4179-88. PubMed ID: 7594573
    [Abstract] [Full Text] [Related]

  • 10. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H, Zhao K, Wang L, Zheng Y, Zhang G, Mai H, Han Y, Yang L, Guo S.
    J Surg Res; 2010 May 15; 160(2):315-24. PubMed ID: 19524257
    [Abstract] [Full Text] [Related]

  • 11. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL, Zadach K, Nalesnik M, Ildstad ST.
    Transplantation; 1995 Nov 15; 60(9):971-80. PubMed ID: 7491703
    [Abstract] [Full Text] [Related]

  • 12. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
    Li S, Salgar SK, Thanikachalam M, Murdock AD, Gammie JS, Demetris AJ, Zeevi A, Pham SM.
    J Surg Res; 2006 Dec 15; 136(2):238-46. PubMed ID: 17046021
    [Abstract] [Full Text] [Related]

  • 13. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S, Salgar SK, Kurimoto Y, Yousem S, Pham SM.
    J Surg Res; 2008 May 15; 146(2):289-97. PubMed ID: 18314139
    [Abstract] [Full Text] [Related]

  • 14. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.
    Foster RD, Ascher NL, McCalmont TH, Neipp M, Anthony JP, Mathes SJ.
    Transplantation; 2001 Sep 15; 72(5):791-7. PubMed ID: 11571439
    [Abstract] [Full Text] [Related]

  • 15. The role of alphabeta- and gammadelta-T cells in allogenic donor marrow on engraftment, chimerism, and graft-versus-host disease.
    Huang Y, Cramer DE, Ray MB, Chilton PM, Que X, Ildstad ST.
    Transplantation; 2001 Dec 27; 72(12):1907-14. PubMed ID: 11773887
    [Abstract] [Full Text] [Related]

  • 16. Composite tissue allotransplantation in chimeric hosts part II. A clinically relevant protocol to induce tolerance in a rat model.
    Prabhune KA, Gorantla VS, Perez-Abadia G, Francois CG, Vossen M, Laurentin-Perez LA, Breidenbach WC, Wang GG, Anderson GL, Pidwell DJ, Barker JH, Maldonado C.
    Transplantation; 2003 Dec 15; 76(11):1548-55. PubMed ID: 14702522
    [Abstract] [Full Text] [Related]

  • 17. Dissociation between peripheral blood chimerism and tolerance to hindlimb composite tissue transplants: preferential localization of chimerism in donor bone.
    Rahhal DN, Xu H, Huang WC, Wu S, Wen Y, Huang Y, Ildstad ST.
    Transplantation; 2009 Sep 27; 88(6):773-81. PubMed ID: 19920776
    [Abstract] [Full Text] [Related]

  • 18. A nonlethal conditioning approach to achieve engraftment of xenogeneic rat bone marrow in mice and to induce donor-specific tolerance.
    Neipp M, Exner BG, Ildstad ST.
    Transplantation; 1998 Oct 27; 66(8):969-75. PubMed ID: 9808477
    [Abstract] [Full Text] [Related]

  • 19. In vivo depletion of host CD4+ and CD8+ cells permits engraftment of bone marrow stem cells and tolerance induction with minimal conditioning.
    Exner BG, Colson YL, Li H, Ildstad ST.
    Surgery; 1997 Aug 27; 122(2):221-7. PubMed ID: 9288126
    [Abstract] [Full Text] [Related]

  • 20. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
    Chen B, Xu H, Corbin DR, Ildstad ST.
    Transplantation; 2012 Oct 15; 94(7):671-8. PubMed ID: 22948444
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.